FreedomWorks Foundation Submits Comments on Dairy Alternative Labeling
FreedomWorks Foundation’s Regulatory Action Center (RAC) submitted formal written comments to the Food and Drug Administration (FDA) to oppose their proposed rule concerning the labeling of dairy alternatives. This rule…
Regulatory Action Center Review – January 23, 2019
Welcome to FreedomWorks Foundation’s second regulatory review of 2019! Our Regulatory Action Center proudly updates you with our favorite tidbits from the swamp. We want to smash barriers between bureaucracy…
House Reconsiders Democrats’ Move to Deny Hope to Terminally Ill Patients
Sarah Anderson co-authored this post. For more than a year, so-called “progressives” have seethed hyperbolic rhetoric claiming that people would die from Republican health insurance reform and tax…
CREATES Act Opponents are Direly Wrong
Once in a long while, Congress finds a bipartisan fix for dire issues like prescription drug prices. The CREATES Act is such a solution that would remedy price-hiking loopholes abused…
A Free Market Approach to Prescription Drugs
In his first State of the Union speech, President Trump once again promised to lower the swelling costs of prescription drugs. The question is – will the administration do it…
Jail Time for Too Much Meat on a Sandwich?
Time and time again, the federal government has encroached into a sector of the economy and imposed a one-size-fits-all regulation that stifles competition, hurts small businesses, and creates troubling criminal…
FreedomWorks Foundation’s Formal Comment on FDA’s Proposed Smokeless Tobacco Ban
Today, FreedomWorks Foundation’s Regulatory Action Center (RAC) submitted comments to the Food and Drug Administration (FDA) opposing the proposed Tobacco Product Standard for N-Nitrosonornicotine (NNN) Level in Finished Smokeless…
Restoring Article I of the Constitution
Throughout the last century, Congress has been delegating a lot of its legislative authority to the executive branch through the creation of new administrative agencies to make new regulations.
Capitol Hill Update: April 24, 2017
Schedule: The House and Senate are in session this week. House: It will be a busy week in the House, with government funding and, possibly, the American Health Care Act,…
Scott Gottlieb and Reforming the FDA
In his first address to Congress last month, President Trump criticized the Food and Drug Administration’s “slow and burdensome” drug approval process for preventing “too many advances…from reaching those in…